PaxMedica, Inc.
PXMD
$0.0001
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 26.43% | 11.46% | -23.56% | -425.41% | -579.59% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -71.51% | -52.99% | -17.20% | 462.89% | 260.58% |
| Change in Net Operating Assets | 200.60% | 122.41% | 563.62% | -265.16% | -347.05% |
| Cash from Operations | 10.88% | -25.33% | -77.37% | -163.80% | -149.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -172.06% | -100.00% | -100.00% | -75.56% |
| Total Debt Repaid | -114.14% | -114.14% | -- | -- | -- |
| Issuance of Common Stock | -50.70% | 31.46% | 130.09% | 33.17% | -- |
| Repurchase of Common Stock | 84.80% | 75.35% | 78.08% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -1,899.14% | -592.46% | -340.20% |
| Cash from Financing | -51.37% | -32.57% | 80.33% | -15.09% | 1,528.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -189.69% | -159.93% | 92.66% | -217.15% | 191.19% |